Carl V. Asche, MBA, MSc, PhD, is currently a Research Professor in the Department of Pharmacotherapy at the University of Utah College of Pharmacy in Salt Lake City and Executive Director of the Department's Pharmacotherapy Outcomes research Center. He also serves as the Director of the Post-Doctoral Fellowship Program in the Department of Pharmacotherapy along with appointments as Research Service WOC employee, Veteran's Affairs, Salt Lake City Healthcare System and Associate Member, Cancer Control and Population Science Research Program at the Huntsman Cancer Institute. His Research focuses on the use of comparative effectiveness research and cost-effectiveness analysis in health care decision making. His academic work has comprised of authoring and co-authoring over 150 peer-reviewed publications appearing in medical and economic literature. He serves on numerous national and international health economics-focused boards and committees, including editorial, grant review and advisory bodies. Dr. Asche's current research is funded by a variety of federal agencies and pharmaceutical companies. He earned his PhD (Economics) from the University of Surrey, MSc (Health Economics) from the University of York, and MBA from the City University of Seattle.
RELATED LINKS
Education History
| Doctoral Training |
University of Surrey |
PhD (Economics) |
|---|---|---|
| MSc (Health Economics) |
Selected Publications
Journal Article
-
Asche C, Demeunynck M. Antitumor carbazoles. Anticancer Agents Med Chem. 2007 Mar;7(2):247-67. doi: 10.2174/187152007780058678 PMID: 17348830
-
Asche C. Antitumour quinones. Mini Rev Med Chem. 2005 May;5(5):449-67. doi: 10.2174/1389557053765556. PMID: 15892687
-
Asche CV, Kim M, Brown A, Golden A, Laack TA, Rosario J, Strother C, Totten VY, Okuda Y. Communicating Value in Simulation: Cost-Benefit Analysis and Return on Investment. Acad Emerg Med. 2018 Feb;25(2):230-237. doi: 10.1111/acem.13327. Epub 2017 Nov 30. PMID: 28965366